Loading stock data…
Loading stock data…
Earnings reportIn 12 days
Tuesday, July 28 · EPS est. -1.0918
Confirmed dates from data providers — they can still change. Information only, not investment advice.
US$4.88
Get one email when LENZ crosses your level. Checked every 15 minutes during market hours.
▼ -0.11 (-2.20%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
29.9
OversoldAbove 70 can signal overbought; below 30, oversold.
MACD
-0.50
Bearish momentumMACD below its signal line (-0.48).
50-day average
6.83
Price belowShort-term trend reference.
200-day average
16.87
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
LENZ Therapeutics, Inc. is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia. This innovative once-daily eye drop aims to restore near vision, addressing the gradual loss of focusing ability that affects adults typically over age 45, offering a pharmaceutical alternative to reading glasses for a broad patient population. The company is actively co…
www.lenz-tx.com6 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-07-01)
6 strong buy · 5 buy · 2 hold · 0 sell · 0 strong sell (13 analysts, 2026-06-01)
6 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (13 analysts, 2026-05-01)
6 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (13 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-11 | -1.07 | -1.32 | ✗ Miss |
| 2026-03-24 | -0.92 | -1.16 | ✗ Miss |
| 2026-03-06 | -0.22 | 0.76 | ✓ Beat |
| 2026-01-20 | 0.88 | 0.89 | ✓ Beat |
| 2025-11-05 | -0.69 | -0.59 | ✓ Beat |
| 2025-10-06 | 0.82 | 0.85 | ✓ Beat |
| 2025-07-30 | -0.54 | -0.53 | ✓ Beat |
Companies in the same industry, via Finnhub